Investigating the clinical factors and comedications associated with circulating levels of atorvastatin and its major metabolites in secondary prevention. (2020)
Attributed to:
Pharmacogenetics of statin-induced muscle toxicity: exploration using the UK General Practice Research Database (G
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bcp.14133
PubMed Identifier: 31656041
Publication URI: http://europepmc.org/abstract/MED/31656041
Type: Journal Article/Review
Volume: 86
Parent Publication: British journal of clinical pharmacology
Issue: 1
ISSN: 0306-5251